Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05199259 · ClinicalTrials.gov registry record

Multi-analyte Blood Test Clinical Trial

A clinical trial of Hepatocellular Carcinoma and Liver Cancer, sponsored by Helio Genomics.

Recruiting
Registry status
1,200
Enrollment target
7
Study locations

NCT05199259 is a study of Hepatocellular Carcinoma and Liver Cancer that is actively recruiting participants, run by Helio Genomics. The registered enrollment target is 1,200 participants, above the 249-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (382% higher). The trial reports 7 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05199259, a study of Hepatocellular Carcinoma and Liver Cancer, is actively recruiting participants, sponsored by Helio Genomics.

RECRUITING
Registry status
1,200 participants
Enrollment target
7
Study locations

Study Summary

The objective of this study is the acquisition of whole blood samples and serum samples from participants with untreated Hepatocellular Carcinoma (HCC) and subjects undergoing Hepatocellular Carcinoma (HCC) surveillance. These samples will be used for research purposes to develop and validate the Helio multi-analyte blood test.

Conditions Studied

Hepatocellular Carcinoma Liver Cancer Liver Cirrhosis HCC

Interventions

  • DIAGNOSTIC_TEST Multi-analyte Blood Test

Study Locations (7)

Texas

  • South Texas Research Institute - Edinburg
  • Texas Gastro Research - El Paso
  • Impact Research Institute - Waco

California

  • Providence Facey Medical Foundation - Mission Hills

Florida

  • Guardian Angel Research Center - Tampa

Maryland

  • GI Research Mercy Medical Center - Baltimore

Virginia

  • Digestive & Liver Disease Specialist - Norfolk

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2022-03-01
Est. Completion 2025-03

Sponsor

Helio Genomics

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05199259

The ClinicalTrials.gov registry entry for NCT05199259 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 249-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (382% higher). The listed sponsor is Helio Genomics, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Hepatocellular Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Multi-analyte Blood Test is the first listed.

NCT05199259 reports 7 study locations spanning 5 distinct geographic areas - top geographies include Texas, California, Florida.

Frequently Asked Questions

What is clinical trial NCT05199259 about?

NCT05199259 is a clinical study titled "Multi-analyte Blood Test Clinical Trial". The objective of this study is the acquisition of whole blood samples and serum samples from participants with untreated Hepatocellular Carcinoma (HCC) and subjects undergoing Hepatocellular Carcinoma (HCC) surveillance. These samples will be used for research purposes to develop and validate the He...

What is the current status of trial NCT05199259?

This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2022-03-01. Estimated completion is 2025-03.

What conditions does trial NCT05199259 study?

This clinical trial studies the following conditions: Hepatocellular Carcinoma, Liver Cancer, Liver Cirrhosis, HCC.

What interventions are being tested in trial NCT05199259?

The interventions under investigation include: Multi-analyte Blood Test (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05199259?

This trial is sponsored by Helio Genomics, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05199259 being conducted?

This trial has 7 study locations across California, Florida, Maryland, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hepatocellular Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hepatocellular Carcinoma

All registered trials for this condition

Liver Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.